Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBenitec Biopharma Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

Benitec Biopharma Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jun 29, 2026BUCHI J KEVINDirector51,813Common Stock$640.9KGift given
May 26, 2026Friedman David MatthewDirector35,000Options (right to buy)$393.1KGrant / award
Jan 22, 2026Mates SharonDirector31,500Options (right to buy)$367.9KGrant / award
Dec 29, 2025SUVRETTA CAPITAL MANAGEMENT, LLCDirector, 10% Owner77,387Common stock, par value $0.0001 per share$1MBuy
Dec 26, 2025SUVRETTA CAPITAL MANAGEMENT, LLCDirector, 10% Owner16,836Common stock, par value $0.0001 per share$220.6KBuy
Dec 23, 2025SUVRETTA CAPITAL MANAGEMENT, LLCDirector, 10% Owner50,000Common stock, par value $0.0001 per share$575KBuy
Dec 22, 2025SUVRETTA CAPITAL MANAGEMENT, LLCDirector, 10% Owner19,542Common stock, par value $0.0001 per share$224.7KBuy
Dec 19, 2025SUVRETTA CAPITAL MANAGEMENT, LLCDirector, 10% Owner16,384Common stock, par value $0.0001 per share$188.4KBuy
Dec 18, 2025SUVRETTA CAPITAL MANAGEMENT, LLCDirector, 10% Owner10,215Common stock, par value $0.0001 per share$122.4KBuy
Dec 1, 2025BUCHI J KEVINDirector35,000Options (right to buy)$453.6KGrant / award
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$8.99Close ยท Oct 7, 2026